Literature DB >> 32716699

Delayed Denosumab Injections and Fracture Risk.

Kristine E Ensrud1, John T Schousboe2.   

Abstract

Entities:  

Year:  2020        PMID: 32716699     DOI: 10.7326/M20-4802

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  1 in total

1.  Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab Discontinuation.

Authors:  Athanasios D Anastasilakis; Stergios A Polyzos; Maria P Yavropoulou; Natasha M Appelman-Dijkstra; Charikleia Ntenti; Stylianos Mandanas; Athanasios Papatheodorou; Polyzois Makras
Journal:  Calcif Tissue Int       Date:  2021-01-02       Impact factor: 4.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.